Advisory Board November 21, 2024
According to a new study published in the Journal of Clinical Investigation, SARS-CoV-2, the virus that causes COVID-19, may “trigger the development of a unique type of immune cell of anti-cancer properties.”
The foundational forces affecting pharma today and beyond
Study details and key findings
During the pandemic, some doctors anecdotally reported that some of their patients with cancer who had severe COVID-19 saw their tumors either shrink or grow more slowly.
“We didn’t know if it was real, because these patients were so sick,” said Ankit Bharat, chief of thoracic surgery at Northwestern University. “Was it because the immune system was so triggered by COVID-19 that it also started to kill cancer cells? What was it?”
To determine if...
Today's Sponsors
Today's Sponsor